The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net operating revenues | 12,485 |
| Salaries and benefits | 5,412 |
| Supplies | 1,864 |
| Medical specialist fees | 648 |
| Other segment items | 3,053 |
| Depreciation and amortization | 426 |
| Interest expense | 872 |
| Interest income | 2 |
| Impairment and (gain) loss on sale of businesses, net | -406 |
| Gain from early extinguishment of debt | 97 |
| Equity in earnings of unconsolidated affiliates | 9 |
| Provision for income taxes | 48 |
| Net income (loss) | 676 |
| Depreciation and amortization | 426 |
| Deferred income taxes | -243 |
| Stock-based compensation expense | 11 |
| Impairment and (gain) loss on sale of businesses, net | -406 |
| Gain from early extinguishment of debt | 97 |
| Other non-cash expenses, net | -173 |
| Patient accounts receivable | -99 |
| Supplies, prepaid expenses and other current assets | -44 |
| Accounts payable, accrued liabilities and income taxes | -36 |
| Other | 104 |
| Net cash provided by operating activities | 543 |
| Acquisitions of facilities and other related businesses | 1 |
| Purchases of property and equipment | 335 |
| Proceeds from disposition of hospitals and other ancillary operations | 1,254 |
| Proceeds from sale of property and equipment | 8 |
| Purchases of available-for-sale debt securities and equity securities | 139 |
| Proceeds from sales of available-for-sale debt securities and equity securities | 123 |
| Purchases of investments in unconsolidated affiliates | 0 |
| Increase in other investments | 63 |
| Net cash provided by (used in) investing activities | 847 |
| Repurchase of restricted stock shares for payroll tax withholding requirements | 2 |
| Deferred financing costs and other debt-related costs | 16 |
| Proceeds from noncontrolling investors in joint ventures | 2 |
| Redemption of noncontrolling investments in joint ventures | 3 |
| Distributions to noncontrolling investors in joint ventures | 164 |
| Other borrowings | 41 |
| Issuance of long-term debt | 2,470 |
| Proceeds from abl facility | 3,021 |
| Repayments of long-term indebtedness | 6,516 |
| Net cash used in financing activities | -1,167 |
| Net change in cash and cash equivalents | 223 |
| Cash and cash equivalents at beginning of period | 37 |
| Cash and cash equivalents at end of period | 260 |
COMMUNITY HEALTH SYSTEMS INC (CYH)
COMMUNITY HEALTH SYSTEMS INC (CYH)